Versant Capital Management, Inc Amgen Inc Transaction History

Versant Capital Management, Inc

$431 Million
Q3 2024

A detailed history of Versant Capital Management, Inc transactions in Amgen Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,067 shares of AMGN stock, worth $315,757. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,067

Previous 951 12.2%

Holding current value

$315,757

Previous $297,000 15.49%

% of portfolio

0.08%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $35,888 - $39,136	116 Added 12.2%	1,067 $343,000
Q2 2024 Jul 05, 2024	SELL	$262.75 - $319.31 $3,415 - $4,151	-13 Reduced 1.35%	951 $297,000
Q1 2024 Apr 03, 2024	BUY	$268.87 - $324.56 $8,603 - $10,385	32 Added 3.43%	964 $274,000
Q4 2023 Jan 08, 2024	SELL	$255.7 - $288.46 $3,068 - $3,461	-12 Reduced 1.27%	932 $268,000
Q3 2023 Oct 11, 2023	BUY	$218.65 - $271.46 $655 - $814	3 Added 0.32%	944 $253,000
Q2 2023 Jul 10, 2023	SELL	$214.27 - $253.37 $37,711 - $44,593	-176 Reduced 15.76%	941 $208,000
Q1 2023 Apr 10, 2023	BUY	$225.79 - $275.2 $5,193 - $6,329	23 Added 2.1%	1,117 $270,000
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $458 - $582	2 Added 0.18%	1,094 $0
Q3 2022 Dec 30, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.09%	1,092 $246,000
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $141,648 - $156,700	646 Added 145.17%	1,091 $264,000
Q4 2021 Jan 06, 2022	SELL	$198.88 - $227.6 $1,193 - $1,365	-6 Reduced 1.33%	445 $100,000
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $2,334 - $2,735	-11 Reduced 2.38%	451 $96,000
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $29,431 - $32,651	-126 Reduced 21.43%	462 $113,000
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $665 - $775	3 Added 0.51%	588 $146,000
Q2 2020 Jul 16, 2020	BUY	$197.81 - $242.74 $593 - $728	3 Added 0.52%	585 $138,000
Q1 2020 Apr 17, 2020	SELL	$182.24 - $241.7 $9,658 - $12,810	-53 Reduced 8.35%	582 $117,000
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $946 - $1,216	-5 Reduced 0.78%	635 $153,000
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $3,830 - $4,589	22 Added 3.56%	640 $123,000
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $35,673 - $41,817	-214 Reduced 25.72%	618 $113,000
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $121,906 - $137,415	674 Added 426.58%	832 $158,000
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $118,831 - $133,949	-657 Reduced 80.61%	158 $158,000
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $370 - $417	-2 Reduced 0.24%	815 $168,000
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $508 - $594	-3 Reduced 0.37%	817 $139,000
Q4 2017 Apr 19, 2018	BUY	$168.79 - $188.59 $6,414 - $7,166	38 Added 4.86%	820 $142,000
Q3 2017 Apr 23, 2018	SELL	$167.29 - $191.0 $22,918 - $26,167	-137 Reduced 14.91%	782 $145,000
Q4 2016 Apr 23, 2018	SELL	N/A	-45 Reduced 4.67%	919 $134,000
Q3 2016 Apr 23, 2018	SELL	N/A	-25 Reduced 2.53%	964 $160,000
Q2 2016 Apr 23, 2018	SELL	N/A	-23 Reduced 2.27%	989 $150,000
Q1 2016 Apr 23, 2018	SELL	N/A	-28 Reduced 2.69%	1,012 $151,000
Q4 2015 Apr 23, 2018	BUY	N/A	1,040	1,040 $168,000

Others Institutions Holding AMGN

# of Institutions

3,113

Shares Held

410M

Call Options Held

Put Options Held

6.15M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Amgen Inc Transaction History